Vince Pozsgay

Affiliations: 
National Institutes of Health - NICHD 
Google:
"Vince Pozsgay"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Pozsgay V, Kubler-Kielb J, Coxon B, et al. (2012) Synthetic oligosaccharides as tools to demonstrate cross-reactivity between polysaccharide antigens. The Journal of Organic Chemistry. 77: 5922-41
Pozsgay V, Kubler-Kielb J, Coxon B, et al. (2011) Synthesis and antigenicity of BBGL-2 glycolipids of Borrelia burgdorferi, the causative agent of Lyme disease. Carbohydrate Research. 346: 1551-63
Kubler-Kielb J, Vinogradov E, Lagergård T, et al. (2011) Oligosaccharide conjugates of Bordetella pertussis and bronchiseptica induce bactericidal antibodies, an addition to pertussis vaccine. Proceedings of the National Academy of Sciences of the United States of America. 108: 4087-92
Kubler-Kielb J, Vinogradov E, Mocca C, et al. (2010) Immunochemical studies of Shigella flexneri 2a and 6, and Shigella dysenteriae type 1 O-specific polysaccharide-core fragments and their protein conjugates as vaccine candidates. Carbohydrate Research. 345: 1600-8
Robbins JB, Kubler-Kielb J, Vinogradov E, et al. (2009) Synthesis, characterization, and immunogenicity in mice of Shigella sonnei O-specific oligosaccharide-core-protein conjugates. Proceedings of the National Academy of Sciences of the United States of America. 106: 7974-8
Kubler-Kielb J, Vinogradov E, Ben-Menachem G, et al. (2008) Saccharide/protein conjugate vaccines for Bordetella species: preparation of saccharide, development of new conjugation procedures, and physico-chemical and immunological characterization of the conjugates. Vaccine. 26: 3587-93
Pozsgay V. (2008) Recent developments in synthetic oligosaccharide-based bacterial vaccines. Current Topics in Medicinal Chemistry. 8: 126-40
Pozsgay V, Kubler-Kielb J, Schneerson R, et al. (2007) Effect of the nonreducing end of Shigella dysenteriae type 1 O-specific oligosaccharides on their immunogenicity as conjugates in mice. Proceedings of the National Academy of Sciences of the United States of America. 104: 14478-82
Pozsgay V, Kubler-Kielb J. (2007) Synthesis of an experimental glycolipoprotein vaccine against Lyme disease. Carbohydrate Research. 342: 621-6
Pozsgay V, Ekborg G, Sampathkumar SG. (2006) Synthesis of hexa- to tridecasaccharides related to Shigella dysenteriae type 1 for incorporation in experimental vaccines. Carbohydrate Research. 341: 1408-27
See more...